Nasdaq FDA - Search News

FDA Approves 1st Non-Opioid Pain Drug in 20 Years

Is Vertex Pharmaceuticals a Buy Now That the FDA Approved Its New Pain Drug?

Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) are down about 9% from a peak the stock set in November,

SchaeffersResearch.com · 2d

Biotech Stock Rises After FDA Approves Non-Opioid Painkiller

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) stock is up 6% at $465.02 at last glance, after the U.S. Food and Drug Administration (FDA) approved the biotech's new non-opioid painkiller, Journavx. In a statement to the press,

Hosted on MSN · 3d

FDA approves Vertex's first-in-class non-opioid analgesic for acute pain

Today, the U.S. Food and Drug Administration (FDA) gave its approval to Vertex Pharmaceuticals' (NASDAQ: NASDAQ:VRTX) Journavx (suzetrigine) 50 milligram oral tablets. This new drug is a non-opioid analgesic,

15hon MSN

Vertex Pharmaceuticals Just Won a Huge FDA Approval. Is the Biotech Stock a No-Brainer Buy?

Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 ...

Nasdaq4d

FDA Clears Allogene's IND for CAR T Therapy in Autoimmune Diseases

Allogene Therapeutics, Inc. ALLO announced that the FDA has cleared its investigational ... the average surprise being 172.72%. 7 Best Stocks for the Next 30 Days Just released: Experts distill ...

Biotech Stocks Facing FDA Decision In February 2025

February is observed as American Heart Month, a period dedicated to raising awareness about heart health. The first American Heart ...

2don MSN

GE HealthCare Technologies Inc. (GEHC): FDA-Cleared AI Ultrasound Systems for Women’s Health

We recently published a list of 10 AI News and Ratings Too Important to Miss. In this article, we are going to take a look at ...

Nasdaq6d

Invivyd Submits Updated Immunobridging Data To FDA For PEMGARDA EUA Amendment

Invivyd has continued to provide timely updates to the FDA since its initial submission ... author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew ...

3don MSN

Axsome gets FDA approval for Symbravo for migraine

Axsome Therapeutics (NASDAQ:AXSM) has received FDA approval for its drug Symbravo for the acute treatment of migraine with or ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results